Gailey Eye Clinic is proud to have a Clinical Research Department. Our doctors and full-time research team are committed to conducting clinical trials to encourage cutting edge treatments in the field of ophthalmology. To ensure the rights and safety of our research patients, we are overseen by the Food and Drug Administration and national institutional review boards. We are also part of the Diabetic Retinopathy Clinical Research Network (DRCR).

We are currently conducting trials in the following areas:

• Dry Macular Degeneration
• Wet Macular Degeneration Glaucoma
• Retinal Vein Occlusion
• Diabetic Retinopathy

If you would like more information regarding any of our current clinical trials, please email our research department at research@gaileyeyeclinic.com or visit clinicaltrials.gov.

What are clinical trials?

Clinical trials are research studies that allow patients to participate in experimental, research treatments that are not offered to the general public. Clinical trials are generally sponsored by pharmaceutical companies, governmental agencies, or non-profit institutions. These therapies are generally not currently approved by the Food and Drug Administration (FDA) but data from these studies is often used to help obtain FDA approval.

Participation in clinical trials is never mandatory. We participate in clinical trials in order to be able to offer our patients with the latest therapies available for eye diseases.

How can I participate in a clinical trial?

Patients who are interested in participating in clinical trials should contact our Research Coordinator to inquire about current trials and eligibility.  Please note that not everyone will be eligible to participate in the trial, as the criteria for inclusion (set by the FDA) are often very strict.

Reasons to participate in a clinical trial:

• Feeling of contribution to the wellbeing of patients with similar conditions
• More personalized doctor visits based on study requirements which can enhance your knowledge of your condition and treatment
• Free office visits, including all testing and medications related to the study
• Possible access to new medications before they are marketed
• Reimbursement for time and travel expenses for most studies